Statements (54)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:drug
|
gptkbp:bfsLayer |
2
|
gptkbp:bfsParent |
gptkb:physicist
|
gptkbp:approves |
1970s
|
gptkbp:brand |
gptkb:Canesten
|
gptkbp:clinical_trial |
studies on efficacy
studies on safety studies on dosage |
gptkbp:contraindication |
hypersensitivity to clotrimazole
|
gptkbp:current_use |
athlete's foot
thrush ringworm jock itch |
gptkbp:dosage_form |
gptkb:tablet
gptkb:skincare_product pessary |
gptkbp:duration |
varies by infection
|
gptkbp:formulation |
gptkb:tablet
gptkb:skincare_product vaginal pessary |
https://www.w3.org/2000/01/rdf-schema#label |
Canesten
|
gptkbp:ingredients |
clotrimazole
|
gptkbp:is_available_in |
gptkb:various_countries
|
gptkbp:is_available_on |
gptkb:drug
|
gptkbp:is_used_for |
treating fungal infections
|
gptkbp:manager |
oral
topical vaginal |
gptkbp:manufacturer |
gptkb:physicist
|
gptkbp:marketed_as |
Canesten Cream
Canesten Oral Tablet Canesten Pessary |
gptkbp:packaging |
gptkb:collection
blister pack tube |
gptkbp:pharmacokinetics |
excreted in urine
metabolized in liver absorbed through skin inhibits ergosterol synthesis fungicidal |
gptkbp:regulatory_compliance |
approved by FDA
approved by EMA approved by TGA |
gptkbp:scholarships |
avoid contact with eyes
consult doctor if symptoms persist do not use on broken skin follow instructions on package |
gptkbp:shelf_life |
3 years
|
gptkbp:side_effect |
skin irritation
itching burning sensation |
gptkbp:storage |
keep out of reach of children
keep away from moisture store below 25° C |